INITIAL PUBLIC OFFERING OF 218,800,000 NEW ORDINARY SHARES IN CENGILD MEDICAL BERHAD (“CENGILD MEDICAL”) (“SHARES”) (“IPO SHARES”) IN CONJUNCTION WITH THE LISTING OF AND QUOTATION FOR THE ENTIRE ISSUED SHARE CAPITAL OF CENGILD MEDICAL COMPRISING 818,800,000 SHARES ON THE ACE MARKET OF BURSA MALAYSIA SECURITIES BERHAD INVOLVING: (I) INSTITUTIONAL OFFERING OF 162,860,000 IPO SHARES TO INSTITUTIONAL AND SELECTED INVESTORS, AT THE INSTITUTIONAL PRICE TO BE DETERMINED BY WAY OF BOOKBUILDING (“INSTITUTIONAL PRICE”); AND (II) RETAIL OFFERING OF 55,940,000 IPO SHARES TO THE MALAYSIAN PUBLIC, THE ELIGIBLE DIRECTORS, ELIGIBLE KEY SENIOR MANAGEMENT, ELIGIBLE EMPLOYEES AND PERSONS WHO HAVE CONTRIBUTED TO THE SUCCESS OF CENGILD MEDICAL AND ITS SUBSIDIARIES, AT THE RETAIL PRICE OF RM0.33 PER IPO SHARE (“RETAIL PRICE”), PAYABLE IN FULL UPON APPLICATION AND SUBJECT TO REFUND OF THE DIFFERENCE BETWEEN THE RETAIL PRICE AND THE FINAL RETAIL PRICE (AS DEFINED IN THIS PROSPECTUS) IN THE EVENT THAT THE FINAL RETAIL PRICE IS LESS THAN THE RETAIL PRICE, SUBJECT TO THE CLAWBACK AND REALLOCATION PROVISIONS. THE FINAL RETAIL PRICE WILL BE EQUAL TO THE LOWER OF: (I) THE RETAIL PRICE OF RM0.33 PER IPO SHARE; OR (II) THE INSTITUTIONAL PRICE